J&J applies for COVID-19 vaccine approval in Japan

FILE PHOTO: Empty vials of Johnson & Johnson
FILE PHOTO: Empty vials of Johnson & Johnson's coronavirus disease (COVID-19) vaccine are seen on a table at a vaccination centre in Ronda, Spain, April 23, 2021. REUTERS/Jon Nazca/File Photo

TOKYO (Reuters) - Johnson & Johnson said on Monday it has filed for regulatory approval of its one-shot COVID-19 vaccine in Japan, and that it can begin supplying doses to the country in early 2022 once it wins approval.

Japan has vaccinated less than 5% of its population, the slowest vaccination pace among the world's larger, richer countries.

(Reporting by Ritsuko Ando; Editing by Tom Hogue)

(c) Copyright Thomson Reuters 2021. Click For Restrictions -

Reuters Japan Health United States Asia Europe US